Stock Market News4 months AstraZeneca Receives CHMP’s Approval for Wainzua in Europe Zacks
The CHMP recommends approval for AZN’s Wainzua for treating polyneuropathy associated with hereditary transthyretin-mediated amyloidosis.
XThe CHMP recommends approval for AZN’s Wainzua for treating polyneuropathy associated with hereditary transthyretin-mediated amyloidosis.
X